Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,979 | 577 | 96.5% |
| Education | $330.36 | 6 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,013 | 132 | $0 (2024) |
| Janssen Biotech, Inc. | $1,598 | 120 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $896.30 | 57 | $0 (2024) |
| Lilly USA, LLC | $621.68 | 38 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $526.48 | 31 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $507.74 | 17 | $0 (2024) |
| GENZYME CORPORATION | $404.70 | 22 | $0 (2024) |
| Amgen Inc. | $314.57 | 16 | $0 (2024) |
| LEO Pharma Inc. | $292.68 | 18 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $274.84 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,369 | 72 | ABBVIE INC. ($479.10) |
| 2023 | $1,426 | 74 | E.R. Squibb & Sons, L.L.C. ($308.77) |
| 2022 | $1,315 | 84 | ABBVIE INC. ($459.88) |
| 2021 | $1,467 | 95 | AbbVie Inc. ($294.65) |
| 2020 | $775.81 | 46 | AbbVie Inc. ($185.43) |
| 2019 | $662.21 | 55 | Novartis Pharmaceuticals Corporation ($168.18) |
| 2018 | $1,218 | 86 | Janssen Biotech, Inc. ($261.97) |
| 2017 | $1,077 | 71 | Janssen Biotech, Inc. ($314.25) |
All Payment Transactions
583 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $30.49 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: ACNE | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $27.61 | General |
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.68 | General |
| Category: Immunology | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Immunology | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: ACNE | ||||||
| 09/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Immunology | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $24.61 | General |
| 08/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $15.28 | General |
| 08/12/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Immunology | ||||||
| 08/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Dermatology | ||||||
| 08/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: IMMUNOLOGY | ||||||
| 08/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: IMMUNOLOGY | ||||||
| 07/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 67 | 10,747 | 19,592 | $6.2M | $758,383 |
| 2022 | 76 | 11,787 | 22,059 | $6.7M | $1.1M |
| 2021 | 72 | 11,836 | 22,993 | $5.8M | $1.3M |
| 2020 | 67 | 10,274 | 18,765 | $4.0M | $920,746 |
All Medicare Procedures & Services
282 procedure records from CMS Medicare Utilization — Page 1 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,442 | 1,874 | $464,752 | $127,132 | 27.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 1,489 | 3,827 | $535,780 | $102,853 | 19.2% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 270 | 298 | $461,900 | $64,201 | 13.9% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 249 | 270 | $312,660 | $46,525 | 14.9% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 296 | 460 | $308,200 | $34,277 | 11.1% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 195 | 208 | $249,808 | $33,305 | 13.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 951 | 1,230 | $332,100 | $30,598 | 9.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 508 | 593 | $183,830 | $22,137 | 12.0% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 258 | 302 | $223,782 | $21,986 | 9.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 925 | 1,063 | $669,690 | $19,578 | 2.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 202 | 249 | $136,950 | $16,801 | 12.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 196 | 271 | $124,931 | $15,123 | 12.1% |
| 11643 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | Office | 2023 | 137 | 151 | $177,123 | $14,422 | 8.1% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 175 | 228 | $136,800 | $14,165 | 10.4% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 143 | 166 | $151,890 | $13,742 | 9.0% |
| 17283 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | Office | 2023 | 102 | 122 | $104,920 | $13,647 | 13.0% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2023 | 20 | 20 | $62,120 | $12,406 | 20.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 222 | 239 | $40,630 | $11,527 | 28.4% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 102 | 104 | $58,240 | $10,615 | 18.2% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2023 | 42 | 44 | $72,952 | $10,567 | 14.5% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 114 | 134 | $67,536 | $9,436 | 14.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 861 | 5,643 | $276,507 | $8,258 | 3.0% |
| 11604 | Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm | Office | 2023 | 85 | 92 | $79,764 | $7,601 | 9.5% |
| 11623 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | Office | 2023 | 83 | 92 | $64,308 | $7,341 | 11.4% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 312 | 415 | $135,705 | $6,756 | 5.0% |
About Dr. Jon Davis, MD
Dr. Jon Davis, MD is a Dermatology healthcare provider based in Evansville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2009. The National Provider Identifier (NPI) number assigned to this provider is 1053549139.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jon Davis, MD has received a total of $9,309 in payments from pharmaceutical and medical device companies, with $1,369 received in 2024. These payments were reported across 583 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($8,979).
As a Medicare-enrolled provider, Davis has provided services to 44,644 Medicare beneficiaries, totaling 83,409 services with total Medicare billing of $4.1M. Data is available for 4 years (2020–2023), covering 282 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Evansville, IN
- Active Since 06/26/2009
- Last Updated 04/27/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1053549139
Products in Payments
- SKYRIZI (Biological) $987.30
- TREMFYA (Drug) $768.94
- TALTZ (Drug) $583.61
- COSENTYX (Biological) $572.98
- DUPIXENT (Biological) $516.84
- Sotyktu (Drug) $507.74
- RINVOQ (Biological) $465.24
- Tremfya (Drug) $381.29
- EUCRISA (Drug) $262.62
- Humira (Biological) $244.11
- STELARA (Biological) $226.36
- HUMIRA (Biological) $220.31
- Ilumya (Biological) $188.41
- REMICADE (Biological) $187.22
- Enbrel (Biological) $182.47
- ILUMYA (Biological) $173.22
- ENSTILAR (Drug) $170.71
- Cimzia (Drug) $160.89
- Otezla (Drug) $152.94
- COSENTYX (Drug) $130.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Evansville
Dr. Charles Hudson, M.d, M.D
Dermatology — Payments: $255,404
Dr. Karl Staser, Md, MD
Dermatology — Payments: $17,278
Dr. Celine Mestel, M.d, Phd, M.D, PHD
Dermatology — Payments: $11,824
Jamie Mull, Md, MD
Dermatology — Payments: $9,501
Kirk Ashburn, A.r.n.p, A.R.N.P
Dermatology — Payments: $8,833
Joseph Tadros, Md, MD
Dermatology — Payments: $4,228